26: Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology–based combinations
26:对CONTACT-03研究中接受一线免疫肿瘤联合疗法治疗的患者进行卡博替尼±阿特珠单抗疗效和安全性亚组分析
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-018-2286-x
Di Giacomo, Anna Maria; Covre, Alessia; Giacobini, Gianluca; Ibrahim, Ramy; Lyman, Jaclyn; Natali, Pier Giorgio; Maio, Michele; McGregor, Bradley A; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta